Delivery Order SPE2DB22D1106-SPE2DB24FEBV5
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% gel-solution in 5ml quantities. The award, valued at $8,263.10, has a completion date of February 23, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Timolol 0.5% Gel-Solution 5ML. The contract has a potential value of $3,080.77 and a period of performance through January 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Timolol 0.5% Gel-Solution (5ml) to support government healthcare programs. The $14,197.90 delivery order was issued by the Defense Logistics Agency (DLA) and has a January 2022 completion date. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,812.02 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,800.72 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 29, 2025, just one day after the award date of October 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,139.23 firm fixed price delivery order is for the supply of Timolol 0.5% gel-solution, a pharmaceutical product, with a period of performance through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,194.34 for the supply of Timolol 0.5% GFS Gel-Solution with a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.77 firm fixed-price delivery order is for the supply of Timolol 0.5% gel-solution, a medication used to treat certain eye conditions. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $15,221.30 for the supply of Timolol 0.25% Gel-Solution 5ML. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of October 20, 2021 and utilizes a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEBV5Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide a pharmaceutical product, Timolol 0.5% GFS Gel-Solution 5ML, with a potential value of $1,224.59 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/26/24 |